Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
about
Platensimycin activity against mycobacterial beta-ketoacyl-ACP synthasesAntidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetesA Review on Platensimycin: A Selective FabF InhibitorReview of Platensimycin and Platencin: Inhibitors of β-Ketoacyl-acyl Carrier Protein (ACP) Synthase III (FabH)Whole-genome sequencing targets drug-resistant bacterial infectionsBacterial lipids: metabolism and membrane homeostasisStructure of 3-oxoacyl-(acyl-carrier protein) synthase II fromThermus thermophilusHB8Structural characterization and comparison of three acyl-carrier-protein synthases from pathogenic bacteriaStructural insights into bacterial resistance to ceruleninAntibacterial targets in fatty acid biosynthesisComparative genome-scale metabolic reconstruction and flux balance analysis of multiple Staphylococcus aureus genomes identify novel antimicrobial drug targetsStructural Characterisation of the Beta-Ketoacyl-Acyl Carrier Protein Synthases, FabF and FabH, of Yersinia pestisTargeting the chromosome partitioning protein ParA in tuberculosis drug discoveryDownregulation of yidC in Escherichia coli by antisense RNA expression results in sensitization to antibacterial essential oils eugenol and carvacrolAntibiotics May Trigger Mitochondrial Dysfunction Inducing Psychiatric DisordersBioprospecting microbial natural product libraries from the marine environment for drug discovery.Targeting the fatty acid biosynthesis enzyme, beta-ketoacyl-acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents.Blueprint for antimicrobial hit discovery targeting metabolic networksCurrent approaches to exploit actinomycetes as a source of novel natural products.Postgenomic strategies in antibacterial drug discovery.Challenges of antibacterial discoveryEngineering of Streptomyces platensis MA7339 for overproduction of platencin and congeners.Systematics-guided bioprospecting for bioactive microbial natural products.Environmental DNA-encoded antibiotics fasamycins A and B inhibit FabF in type II fatty acid biosynthesisA genome-wide inducible phenotypic screen identifies antisense RNA constructs silencing Escherichia coli essential genesAntibiotics and bacterial resistance in the 21st century.Aminobenzoates as building blocks for natural product assembly lines.Exploring anti-TB leads from natural products library originated from marine microbes and medicinal plants.Strain prioritization for natural product discovery by a high-throughput real-time PCR method.Mechanisms of self-resistance in the platensimycin- and platencin-producing Streptomyces platensis MA7327 and MA7339 strains.Expression of the platencin biosynthetic gene cluster in heterologous hosts yielding new platencin congeners.Are natural products still the best source for antibacterial discovery? The bacterial entry factor.Regulated Expression Systems for Mycobacteria and Their ApplicationsFrom nature to the laboratory and into the clinicOccurrence, distribution, dereplication and efficient discovery of thiazolyl peptides by sensitive-resistant pair screening.Engineered Streptomyces platensis strains that overproduce antibiotics platensimycin and platencin.Conformational diversity of bacterial FabH: implications for molecular recognition specificity.FabH mutations confer resistance to FabF-directed antibiotics in Staphylococcus aureusA detailed study of antibacterial 3-acyltetramic acids and 3-acylpiperidine-2,4-diones.Dedicated ent-kaurene and ent-atiserene synthases for platensimycin and platencin biosynthesis.
P2860
Q21562402-ACF22D2D-490B-4B86-8F06-0FB3FC499A9FQ24629052-64564B45-99D2-41BF-BB00-8B9E4983E1EDQ26768294-E032CA2A-898C-4272-908C-3E6DFB8B08D1Q26781411-B975E720-D0D5-4FC4-A9E6-1DAD94807187Q26799059-D0D8C10E-2D0A-4893-BD65-40B08EC34152Q26829512-62D37341-AD1C-44E0-8693-DDAF9402B123Q27650519-8C3FE906-0FA7-45E8-A4F9-AD052840DE57Q27673432-25614529-0C05-4225-9460-A40352F6065DQ27689556-A1F19883-3C0D-488F-9B1E-545B1DA7FD22Q28241394-B1FE8EF8-7685-4795-803D-4E7310251A81Q28241802-2E11D31A-4E51-466C-918E-31A1755F9C6BQ28268619-B3B1BBAD-71FB-4F8E-A981-84E2334B9355Q28486773-B860DEF2-82BD-4205-8FB0-8A2719B0BDB5Q28487584-CC0BDA5E-33E5-4FCC-BB40-62679551C836Q28816988-14D7E5EA-8862-4E6D-A317-4C6D204F564AQ30985377-581A02AC-99EB-4392-96E7-7AFE4FA7B3DCQ33605124-EFDDEF5C-18A0-49C3-962B-26F87C1806B7Q33667030-67A31AD0-BE6D-4ED0-BDC0-7E3E55018EFBQ33712859-1965DF81-41D9-467E-8BEC-C89CC2B85256Q33745572-731AD243-E860-47B7-91E0-C8CC73F8AD0BQ33793074-98C91418-7C43-418E-9E53-EC4EF6EEF8F8Q33793107-0179E7D5-EB51-4A97-BB11-DE8DB59771BCQ34075215-8C2ABCB8-8616-4047-BD27-B69835CC067BQ34120353-DCF54134-D87D-4D63-A711-B3D9A8E41224Q34135985-D27438B8-7C80-456D-BD08-1AB05EF7571DQ34156349-AF796B43-107D-4E03-9F5D-9425A2B44AACQ34230699-9D8168ED-3C08-4834-9554-DF4203D30DACQ34344261-3D8A7812-34D6-4080-8438-46169B8F2971Q34400070-955FAF94-95E1-4F8A-8860-00488C4E8689Q34406049-4FE27F34-B694-4CA6-9603-F0D6B906ED15Q34479743-4E2ECBBB-BBE3-4E0C-96DC-2903C6ABC02FQ34619268-1B9204D6-CB9B-4596-88E0-6E623300BC6DQ34626585-BF14722A-143F-4E65-85B8-880EA42130ACQ34657694-D3A2AB90-BDEA-45A0-905C-F8DA0FFE24AFQ34784122-7E28D7C7-37ED-4B41-8553-B8DFBC027775Q34928039-2B0FCE5D-6E60-4096-B232-5680A434D2D2Q34989730-A237D512-F437-4D66-B005-A62C89F4D72DQ35105888-9C03CDC5-B0CD-424C-89C6-E317A0F668E1Q35170621-2E621A41-1652-48FE-B43C-45F463666049Q35170957-3D69DA17-D7CF-40B0-B0F8-78EBE21FF47C
P2860
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
@ast
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
@en
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
@nl
type
label
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
@ast
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
@en
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
@nl
prefLabel
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
@ast
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
@en
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
@nl
P2093
P2860
P3181
P356
P1476
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
@en
P2093
Andrew Galgoci
Angela Basilio
Doris F Cully
Elizabeth Tinney
Fernando Pelaez
Francisca Vicente
Fred Racine
Hiranthi Jayasuriya
Ignacio González
P2860
P304
P3181
P356
10.1073/PNAS.0700746104
P407
P577
2007-05-01T00:00:00Z